Form 4 for AXGN Axogen, Inc.
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0000805928-26-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-02 | 2026-02-26+ | AXGN | Began Marc A | EVP, GC | F - Tax | $31.48 | -13.2K | 43.3K | -23% | -$414.9K |
| D | 2026-03-02 | 2026-03-01 | AXGN | Began Marc A | EVP, GC | M - OptEx | $0.00 | +11.2K | 54.6K | +26% | $0 |
| D | 2026-03-02 | 2026-02-26 | AXGN | Began Marc A | EVP, GC | A - Grant | $0.00 | +33.8K | 52.1K | +185% | $0 |
| D | 2026-03-02 | 2026-03-01 | AXGN | Began Marc A | EVP, GC | M - OptEx | $0.00 | +11.2K | 11.2K | New | $0 |
| D | 2026-03-02 | 2026-02-26 | AXGN | Began Marc A | EVP, GC | A - Grant | $0.00 | +23.0K | 23.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-01 | F | D | 4,427 | $30.65 | 50,135 | D | — | — | (F4) No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of RSUs. |
| 2 | Common | Common Stock | 2026-03-01 | M | A | 11,250 | $0.00 | 54,562 | D | — | — | (F3) This reflects the number of restricted stock units ("RSUs") that vested on March 1, 2026. |
| 3 | Common | Common Stock | 2026-02-26 | F | D | 8,753 | $31.90 | 43,312 | D | — | — | (F2) No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of performance stock units ("PSUs"). |
| 4 | Common | Common Stock | 2026-02-26 | A | A | 33,780 | $0.00 | 52,065 | D | — | — | (F1) This reflects the number of shares that became vested as of February 26, 2026, upon the attainment and certification of certain performance criteria. |
| 5 | Derivative | Restricted Stock Units | 2026-03-01 | M | A | 11,250 | $0.00 | 11,250 | D | $0.00 · — to — | 11,250 Common Stock | (F5) Each RSU represents a contingent right to receive one share of Axogen, Inc. common stock. (F7) All shares of Axogen, Inc. common stock underlying the RSUs will be fully vested on March 1, 2027 based on a vesting schedule whereby 50% of the aggregate shares vest on March 1, 2025, and an additional 25% of the aggregate shares vest each twelve months thereafter. Vested shares will be delivered to the Reporting Person upon the vesting date. The RSUs were granted pursuant to an inducement award agreement outside of the Issuer's Amended and Restated 2019 Long-Term Incentive Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4). |
| 6 | Derivative | Restricted Stock Units | 2026-02-26 | A | A | 23,000 | $0.00 | 23,000 | D | — · — to — | 23,000 Common Stock | (F5) Each RSU represents a contingent right to receive one share of Axogen, Inc. common stock. (F6) All shares of Axogen Inc. common stock underlying the RSUs will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. |